What’s behind biotech’s recent underperformance? One important factor may be the impending presidential election – and as one exchange-traded fund strategist cited in today’s article explains, “…if history repeats, this pullback may represent an attractive buying opportunity.” What does the history of biotech’s performance leading up to and following presidential elections suggest about buying the biotech dip? CLICK HERE.
Presidential Elections And Buying The Biotech Dip
Tags:Attractive BuysBiotechBiotech DipBiotech InvestingBiotech StocksBiotech UnderperformanceETFsExchange-Traded FundsInvestingPresidential Elections